follow up, eight of 28 patients studied were still HSV-PCR positive. A diagnostic serum:CSF antibody ratio to HSV but not to other viruses was detected in 25 of the 38 HSV-PCR positive patients thus supporting the initial PCR findings. Patients positive by HSV-PCR were concentrated in the age group ) 40 years, and especially in patients aged 60-64 years, of whom nine of 24 A PCR was performed on CSF immediately after receipt in the laboratory (one to three days after collection of the sample). Some samples were frozen and preserved at -20'C until they were assayed. For HSV-PCR a 130 pl CSF sample was centrifuged at 4500 rpm for five minutes at 4°C; 100 pl of the supernatant was treated with proteinase K buffer and the DNA extracted using phenol/diethyl ether and ethanol precipitation. DNA was amplified in a 100 pl reaction mixture containing 50 mM KCI, 10 mM Tris HCI (pH 8 3), Detection ofHSV by PCR in middle aged and elderly people with herpes encephalitis Figure 1 HSV-PCR positivity after the onset of the disease on admission to the hospital. Only the initial positive finding of the patient is included. The figures refer to the number ofpatients studied on each day. Eleven of 57 patients studied on the first day of symptoms were retested on days five to 14 and all were negative on that test except the positive patient who was still positive on day 9. 17 Virus culture was attempted on 122 CSF samples using four different cell lines; African GMK, Vero, human amniotic epithelial cells, and human embryonic skin fibroblasts.
Results
Of 516 patients, 38 (7A4%) were positive by the HSV-PCR test; 32 (6-2%) for HSV-1 and six (1 2%) for HSV-2. The test was positive in the first CSF specimen obtained, usually on admission to hospital; 82% of the samples were obtained within two weeks from the onset of symptoms. The HSV-PCR assay seemed to be of most value for confirming an aetiological diagnosis of HSVE when used during the first week after the onset of symptoms (fig 1) . In one patient, HSV-PCR appeared positive (day 3) after an initial negative finding (day 2). Eight of the 28 patients, on whom follow up tests were performed, remained PCR positive six to 57 days after the first sample. In a 60 year old man with a chronic progressive disease the CSF sample was initially positive to HSV-1, but six months later to HSV-2, and in subsequent tests remained so despite prolonged treatment with acyclovir.
Patients positive for HSV-PCR were concentrated in the age group > 40 years, and in the 60 to 64 year age group HSV-DNA was found in the CSF in nine of 24 patients (fig 2) . In the 1 to 4 year age group no positive findings appeared in any of the 50 children studied. Similarly, in the age group 10 to 24 years samples were negative in all 58 patients with encephalitis. In patients aged 40 to 59 years Koskiniemi, Piiparinen, Mannonen, Rantalaiho, Vaheri and the study group PCR positivity ranged from 13% to 18% of patients with encephalitis studied. Findings of HSV-2 were distributed across the age range. The rate of PCR positivity did not show seasonal variation.
The HSV-PCR was negative in all other patients with encephalitis of known or unknown aetiology including 34 patients with a diagnostic serum:CSF (S/CSF) antibody ratio to some other microbe and 10 patients with a diagnostic S/CSF ratio to HSV (fig 3) . In the HSV-PCR positive group a diagnostic S/CSF antibody ratio to HSV was found in 25 Our findings indicate failure of treatment to eradicate HSV-DNA in the CSF, an observation similar to that found in other studies.8 23 In eight of 28 patients HSV-PCR was still positive six to 57 days after the first positive finding, despite treatment with acyclovir. It has been reported that the highest PCR signals are reached at days five to six of acyclovir treat- With regard to HSV-1 and HSV-2 dual infections, the separation of closely related bands may be difficult using gel electrophoresis.
With microplate detection,25 the separation is clearcut and may be confirmed by Southern blotting.
To confirm the use of the HSV-PCR test for clinical diagnostic purposes we have studied a large series of patients with encephalitis. In older age groups, HSV seems the most prevalent cause of encephalitis and with "ideal" timing, the diagnostic hit rate may be 20% to 35%. In young adults, HSV is a rare cause of encephalitis. The specificity of the HSV-PCR test seemed good in the present study although a "gold standard" reference test is not available in encephalitis cases in general. The PCR test will improve knowledge on viral encephalitis and help to monitor the efficacy of treatment. In the early phase of a CNS disease, PCR is a rapid and sensitive method. At follow up, antibody tests may support the result and possibly establish more diagnoses. The two methods, PCR and antibody determinations, are complementary and should be performed in parallel in clinical laboratory diagnosis.
